request Request a Protocol
ask Ask a question
Favorite

To extract proteins from S. cerevisiae, harvested cells were washed twice with PBS and resuspended in 100 μl of lysis buffer with protease inhibitors and phosphatase inhibitors [150 mM NaCl, 50 mM tris (pH 7.5), 0.15% NP-40, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, leupeptin (1 μg ml−1), pepstatin (1 μg ml−1), 10 mM sodium fluoride, 20 mM β-glycerolphosphate, 10 mM sodium orthovanadate, and 10 mM sodium pyrophosphate]. Cells were disrupted by bead beating using 0.5-mm glass beads. Lysates were clarified by centrifugation at 14,000 revolutions per minute (RPM) for 10 min on a 4°C precooled microcentrifuge. Protein concentration was determined by Bradford assay. Protein samples were mixed with 6× SDS sample buffer and boiled for 5 min at 95°C. SDS-PAGE was performed with 8% separating gel. For Phos-tag SDS-PAGE, 50 μM Phos-tag and 100 μM MnCl2 were mixed with 6% separating gel. For λ phosphatase assay, lysate was incubated with 600 U of λ phosphatase (New England Biolabs), 1× NEBuffer for protein metallophosphatases, and 1 mM MnCl2 at 30°C for 2 hours.

Immunoblotting was performed using the following antibodies: an anti–phospho–mitogen-activated protein kinase (MAPK)/CDK substrates (Cell Signaling Technology, 23255) for phospho-Rad51, an anti-Rfa1 antibody (Abcam, ab221198) for intact Rfa1, an anti-Rad51 antibody (Abcam, ab63798) for intact Rad51, a horseradish peroxidase (HRP)–conjugated anti–influenza hemagglutinin (HA) antibody (Santa Cruz Biotechnology, SC-7392 HRP) for Rad52-HA, an anti-myc antibody (Santa Cruz Biotechnology, SC-40) for Rad52-myc, an HRP-conjugated anti-GFP antibody (Santa Cruz Biotechnology, SC-9996 HRP) for GFP-tagged proteins, an anti-mouse immunoglobulin G (IgG) antibody (Sigma-Aldrich, A9044) for Cdc28-TAP (tandem affinity purification), an anti–glutathione S-transferase (GST) antibody (Santa Cruz Biotechnology, SC-138) for GST-tagged proteins, an polyclonal anti-GFP antibody (Rockland, 600-103-215) for VN (the N-terminal fragment of Venus)/VC (the C-terminal fragment of Venus)–tagged Rad52, and an anti-hexokinase antibody (Rockland, 100-4159) for endogenous hexokinases.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A